151 related articles for article (PubMed ID: 19638725)
21. [De novo CD5-positive diffuse large B-cell lymphoma associated with autoimmune hemolytic anemia presenting as erythroid hypoplasia].
Kuroda H; Matsunaga T; Iyama S; Takimoto R; Shirao S; Kida M; Watanabe H; Konuma Y; Hirayama Y; Kohda K; Niitsu Y
Rinsho Ketsueki; 2006 Jul; 47(7):633-8. PubMed ID: 16910573
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
23. CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement.
Asano H; Imai Y; Ota S; Yamamoto G; Takahashi T; Fukayama M; Kurokawa M
Int J Hematol; 2010 Oct; 92(3):550-2. PubMed ID: 20838960
[TBL] [Abstract][Full Text] [Related]
24. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
25. [Primary splenic CD8-positive diffuse large B-cell lymphoma].
Toyama T; Kubuki Y; Sasaki H; Hidaka T; Okamoto M; Suzuki M; Tsubouchi H
Rinsho Ketsueki; 2001 Dec; 42(12):1187-91. PubMed ID: 11828722
[TBL] [Abstract][Full Text] [Related]
26. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
27. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
28. [Splenic lymphoma of Ki-1 positive B-cell type treated with CHOP].
Terashima T; Tominaga K; Tuji M; Takeuchi H; Watanabe K; Hirashima K
Rinsho Ketsueki; 1992 Jan; 33(1):48-52. PubMed ID: 1312179
[TBL] [Abstract][Full Text] [Related]
29. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
[TBL] [Abstract][Full Text] [Related]
30. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
31. Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.
Xia Y; Li ZM; Shi YX; Xia ZJ; Jiang WQ; Huang HQ
Ai Zheng; 2009 Feb; 28(2):146-9. PubMed ID: 19550126
[TBL] [Abstract][Full Text] [Related]
32. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE
J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992
[TBL] [Abstract][Full Text] [Related]
33. [Case of malignant lymphoma associated with rheumatoid arthritis].
Noguchi T; Nohara J; Sakaguchi Y; Kono T; Terada Y
Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):131-5. PubMed ID: 18318257
[TBL] [Abstract][Full Text] [Related]
34. [Management of diffuse large B-cell lymphoma in the rituximab era].
Kinoshita T
Rinsho Ketsueki; 2009 Oct; 50(10):1342-50. PubMed ID: 19915341
[No Abstract] [Full Text] [Related]
35. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
36. [Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10].
Sakai R; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1105-8. PubMed ID: 16440771
[TBL] [Abstract][Full Text] [Related]
37. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
[TBL] [Abstract][Full Text] [Related]
38. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
39. [A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia].
Kubota Y
Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):453-7. PubMed ID: 16841717
[TBL] [Abstract][Full Text] [Related]
40. [Primary osseous lymphoma with pathological fracture during therapy].
Murakami Y; Yamanouchi J; Azuma T; Ikeda Y; Narumi H; Fujiwara H; Yakushijin Y; Hato T; Yasukawa M
Rinsho Ketsueki; 2009 Mar; 50(3):187-91. PubMed ID: 19352086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
